{"transactions":[{"id":729534,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Stock Option","published_at":"2026-06-23T20:34:21.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":0,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001636178-26-000029","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000029/primarydocument.xml","form_type":"4"}},{"id":729533,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-23T20:34:21.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":1250,"price":541.25,"value":676562.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":18876,"source":{"system":"sec-edgar","filing":"0001636178-26-000029","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000029/primarydocument.xml","form_type":"4"}},{"id":729532,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-23T20:34:21.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":280,"price":539.8261,"value":151151.308,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $539.68 to $539.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20126,"source":{"system":"sec-edgar","filing":"0001636178-26-000029","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000029/primarydocument.xml","form_type":"4"}},{"id":729531,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-23T20:34:21.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":1994,"price":539.1301,"value":1075025.4194,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $538.67 to $539.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20406,"source":{"system":"sec-edgar","filing":"0001636178-26-000029","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000029/primarydocument.xml","form_type":"4"}},{"id":729530,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-23T20:34:21.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":2266,"price":538.234,"value":1219638.244,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $537.67 to $538.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22400,"source":{"system":"sec-edgar","filing":"0001636178-26-000029","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000029/primarydocument.xml","form_type":"4"}},{"id":729529,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-23T20:34:21.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":840,"price":537.1829,"value":451233.636,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $536.65 to $537.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24666,"source":{"system":"sec-edgar","filing":"0001636178-26-000029","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000029/primarydocument.xml","form_type":"4"}},{"id":729528,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-23T20:34:21.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":1091,"price":536.0466,"value":584826.8406,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $535.64 to $536.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25506,"source":{"system":"sec-edgar","filing":"0001636178-26-000029","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000029/primarydocument.xml","form_type":"4"}},{"id":729527,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-23T20:34:21.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":865,"price":534.9849,"value":462761.9385,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $534.57 to $535.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26597,"source":{"system":"sec-edgar","filing":"0001636178-26-000029","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000029/primarydocument.xml","form_type":"4"}},{"id":729526,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-23T20:34:21.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":164,"price":534.0595,"value":87585.758,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $533.57 to $534.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27462,"source":{"system":"sec-edgar","filing":"0001636178-26-000029","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000029/primarydocument.xml","form_type":"4"}},{"id":729525,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-23T20:34:21.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":true,"shares":8750,"price":146.03,"value":1277762.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":27626,"source":{"system":"sec-edgar","filing":"0001636178-26-000029","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000029/primarydocument.xml","form_type":"4"}},{"id":731015,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Stock Option","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":8750,"derivative":{"exercise_price":146.03,"exercise_date":"2020-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731014,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":660,"price":548.9021,"value":362275.386,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $548.69 to $549.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18876,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731013,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":115,"price":547.8052,"value":62997.598,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $547.69 to $548.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19536,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731012,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":265,"price":547.3683,"value":145052.5995,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $546.69 to $547.545. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19651,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731011,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":40,"price":545.19,"value":21807.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":19916,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731010,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":40,"price":543.5268,"value":21741.072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $543.37 to $543.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19956,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731009,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":192,"price":541.8846,"value":104041.8432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $541.82 to $542.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19996,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731008,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":865,"price":541.0582,"value":468015.343,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $540.78 to $541.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20188,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731007,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":2978,"price":540.2175,"value":1608767.715,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $539.78 to $540.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21053,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731006,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":2035,"price":539.4173,"value":1097714.2055,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $538.78 to $539.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24031,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731005,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":1440,"price":538.3079,"value":775163.376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $537.78 to $538.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26066,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731004,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":600,"price":537.2397,"value":322343.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $536.76 to $537.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27506,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731003,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":210,"price":536.2721,"value":112617.141,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $535.73 to $536.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28106,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731002,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":160,"price":534.475,"value":85516.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $534.39 to $534.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28316,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731001,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":400,"price":533.587,"value":213434.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $533.25 to $533.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28476,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":731000,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-22T20:31:58.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":146.03,"value":1460300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":28876,"source":{"system":"sec-edgar","filing":"0001636178-26-000028","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000028/primarydocument.xml","form_type":"4"}},{"id":736736,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Stock Option","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":0,"derivative":{"exercise_price":117.76,"exercise_date":"2023-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736735,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":598,"price":553.7629,"value":331150.2142,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $553.45 to $554.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18876,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736734,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":778,"price":553.0989,"value":430310.9442,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $552.42 to $553.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19474,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736733,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1144,"price":551.9074,"value":631382.0656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $551.40 to $552.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20252,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736732,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":2200,"price":550.8909,"value":1211959.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $550.36 to $551.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21396,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736731,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":800,"price":549.8704,"value":439896.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $549.34 to $550.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23596,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736730,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1616,"price":548.6391,"value":886600.7856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $548.27 to $549.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24396,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736729,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":465,"price":547.7661,"value":254711.2365,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $547.25 to $548.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26012,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736728,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":504,"price":546.5354,"value":275453.8416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $546.16 to $547.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26477,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736727,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":855,"price":545.6344,"value":466517.412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $545.06 to $546.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26981,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736726,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":560,"price":543.5046,"value":304362.576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $542.99 to $543.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27836,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736725,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":240,"price":541.6117,"value":129986.808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $541.57 to $541.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28396,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736724,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":45,"price":540.638,"value":24328.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $539.96 to $540.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28636,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736723,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":74,"price":539.4576,"value":39919.8624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $538.91 to $539.865. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28681,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736722,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":121,"price":538.5233,"value":65161.3193,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $537.91 to $538.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28755,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":736721,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-16T20:35:30.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":117.76,"value":1177600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":28876,"source":{"system":"sec-edgar","filing":"0001636178-26-000027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000027/primarydocument.xml","form_type":"4"}},{"id":740511,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Stock Option","published_at":"2026-06-12T21:26:10.000Z","date":"2026-06-11","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":10000,"derivative":{"exercise_price":117.76,"exercise_date":"2023-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001636178-26-000026","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000026/primarydocument.xml","form_type":"4"}},{"id":740510,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-12T21:26:10.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":320,"price":551.825,"value":176584.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $551.62 to $552.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18876,"source":{"system":"sec-edgar","filing":"0001636178-26-000026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000026/primarydocument.xml","form_type":"4"}},{"id":740509,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-12T21:26:10.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":1560,"price":551.0977,"value":859712.412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $550.62 to $551.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19196,"source":{"system":"sec-edgar","filing":"0001636178-26-000026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000026/primarydocument.xml","form_type":"4"}},{"id":740508,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-12T21:26:10.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":3333,"price":550.0399,"value":1833282.9867,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $549.61 to $550.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20756,"source":{"system":"sec-edgar","filing":"0001636178-26-000026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000026/primarydocument.xml","form_type":"4"}},{"id":740507,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-12T21:26:10.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":1974,"price":549.1055,"value":1083934.257,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $548.60 to $549.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24089,"source":{"system":"sec-edgar","filing":"0001636178-26-000026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000026/primarydocument.xml","form_type":"4"}},{"id":740506,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-12T21:26:10.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":2037,"price":548.0179,"value":1116312.4623,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $547.60 to $548.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26063,"source":{"system":"sec-edgar","filing":"0001636178-26-000026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000026/primarydocument.xml","form_type":"4"}},{"id":740505,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-12T21:26:10.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":134,"price":547.0788,"value":73308.5592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $546.60 to $547.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28100,"source":{"system":"sec-edgar","filing":"0001636178-26-000026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000026/primarydocument.xml","form_type":"4"}},{"id":740504,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-12T21:26:10.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":442,"price":545.1386,"value":240951.2612,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $544.80 to $545.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28234,"source":{"system":"sec-edgar","filing":"0001636178-26-000026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000026/primarydocument.xml","form_type":"4"}},{"id":740503,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-12T21:26:10.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":154,"price":544.369,"value":83832.826,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $543.76 to $544.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28676,"source":{"system":"sec-edgar","filing":"0001636178-26-000026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000026/primarydocument.xml","form_type":"4"}},{"id":740502,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-12T21:26:10.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":46,"price":542.9374,"value":24975.1204,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $542.02 to $543.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28830,"source":{"system":"sec-edgar","filing":"0001636178-26-000026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000026/primarydocument.xml","form_type":"4"}},{"id":740501,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-12T21:26:10.000Z","date":"2026-06-11","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":117.76,"value":1177600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":28876,"source":{"system":"sec-edgar","filing":"0001636178-26-000026","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000026/primarydocument.xml","form_type":"4"}},{"id":745234,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Stock Option","published_at":"2026-06-09T22:06:03.000Z","date":"2026-06-08","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":20000,"derivative":{"exercise_price":117.76,"exercise_date":"2023-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001636178-26-000025","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000025/primarydocument.xml","form_type":"4"}},{"id":745233,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-09T22:06:03.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":80,"price":551.755,"value":44140.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $551.74 to $551.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18876,"source":{"system":"sec-edgar","filing":"0001636178-26-000025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000025/primarydocument.xml","form_type":"4"}},{"id":745232,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-09T22:06:03.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":610,"price":551.2826,"value":336282.386,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $550.63 to $551.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18956,"source":{"system":"sec-edgar","filing":"0001636178-26-000025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000025/primarydocument.xml","form_type":"4"}},{"id":745231,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-09T22:06:03.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":1285,"price":550.0937,"value":706870.4045,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $549.59 to $550.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19566,"source":{"system":"sec-edgar","filing":"0001636178-26-000025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000025/primarydocument.xml","form_type":"4"}},{"id":745230,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-09T22:06:03.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":425,"price":549.3819,"value":233487.3075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $548.59 to $549.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20851,"source":{"system":"sec-edgar","filing":"0001636178-26-000025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000025/primarydocument.xml","form_type":"4"}},{"id":745229,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-09T22:06:03.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":2158,"price":547.9111,"value":1182392.1538,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $547.52 to $548.485. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21276,"source":{"system":"sec-edgar","filing":"0001636178-26-000025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000025/primarydocument.xml","form_type":"4"}},{"id":745228,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-09T22:06:03.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":1888,"price":547.0292,"value":1032791.1296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $546.51 to $547.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23434,"source":{"system":"sec-edgar","filing":"0001636178-26-000025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000025/primarydocument.xml","form_type":"4"}},{"id":745227,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-09T22:06:03.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":1989,"price":546.1339,"value":1086260.3271,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $545.47 to $546.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25322,"source":{"system":"sec-edgar","filing":"0001636178-26-000025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000025/primarydocument.xml","form_type":"4"}},{"id":745226,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-09T22:06:03.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":1565,"price":544.9334,"value":852820.771,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $544.41 to $545.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27311,"source":{"system":"sec-edgar","filing":"0001636178-26-000025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000025/primarydocument.xml","form_type":"4"}},{"id":745225,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-09T22:06:03.000Z","date":"2026-06-08","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":117.76,"value":1177600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":28876,"source":{"system":"sec-edgar","filing":"0001636178-26-000025","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000025/primarydocument.xml","form_type":"4"}},{"id":748614,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Stock Option","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":30000,"derivative":{"exercise_price":117.76,"exercise_date":"2023-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":748613,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":120,"price":550.4767,"value":66057.204,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $550.39 to $550.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18876,"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":748612,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1298,"price":549.0586,"value":712678.0628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $548.55 to $549.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18996,"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":748611,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":2749,"price":548.0374,"value":1506554.8126,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $547.52 to $548.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20294,"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":748610,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1033,"price":547.0035,"value":565054.6155,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $546.52 to $547.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23043,"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":748609,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1129,"price":545.8885,"value":616308.1165,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $545.52 to $546.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24076,"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":748608,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1545,"price":544.9442,"value":841938.789,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $544.51 to $545.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25205,"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":748607,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1086,"price":544.1119,"value":590905.5234,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $543.51 to $544.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26750,"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":748606,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":440,"price":542.7769,"value":238821.836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $542.40 to $543.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27836,"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":748605,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":480,"price":541.1433,"value":259748.784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $540.76 to $541.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28276,"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":748604,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":120,"price":539.6393,"value":64756.716,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $539.29 to $540.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28756,"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":748603,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-05T20:31:30.000Z","date":"2026-06-04","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":117.76,"value":1177600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":28876,"source":{"system":"sec-edgar","filing":"0001636178-26-000024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000024/primarydocument.xml","form_type":"4"}},{"id":755709,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Stock Option","published_at":"2026-06-02T20:33:00.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":40000,"derivative":{"exercise_price":117.76,"exercise_date":"2023-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001636178-26-000023","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000023/primarydocument.xml","form_type":"4"}},{"id":755708,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-02T20:33:00.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":400,"price":554.471,"value":221788.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $553.97 to $554.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18876,"source":{"system":"sec-edgar","filing":"0001636178-26-000023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000023/primarydocument.xml","form_type":"4"}},{"id":755707,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-02T20:33:00.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":280,"price":552.9157,"value":154816.396,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $552.76 to $553.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19276,"source":{"system":"sec-edgar","filing":"0001636178-26-000023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000023/primarydocument.xml","form_type":"4"}},{"id":755706,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-02T20:33:00.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":200,"price":550.81,"value":110162.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":19556,"source":{"system":"sec-edgar","filing":"0001636178-26-000023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000023/primarydocument.xml","form_type":"4"}},{"id":755705,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-02T20:33:00.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1015,"price":550.1955,"value":558448.4325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $549.78 to $550.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19756,"source":{"system":"sec-edgar","filing":"0001636178-26-000023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000023/primarydocument.xml","form_type":"4"}},{"id":755704,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-02T20:33:00.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1185,"price":549.2972,"value":650917.182,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $548.78 to $549.775. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20771,"source":{"system":"sec-edgar","filing":"0001636178-26-000023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000023/primarydocument.xml","form_type":"4"}},{"id":755703,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-02T20:33:00.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1606,"price":548.2639,"value":880511.8234,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $547.76 to $548.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21956,"source":{"system":"sec-edgar","filing":"0001636178-26-000023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000023/primarydocument.xml","form_type":"4"}},{"id":755702,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-02T20:33:00.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1354,"price":547.1116,"value":740789.1064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $546.75 to $547.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23562,"source":{"system":"sec-edgar","filing":"0001636178-26-000023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000023/primarydocument.xml","form_type":"4"}},{"id":755701,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-02T20:33:00.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":2520,"price":546.2253,"value":1376487.756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $545.75 to $546.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24916,"source":{"system":"sec-edgar","filing":"0001636178-26-000023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000023/primarydocument.xml","form_type":"4"}},{"id":755700,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-02T20:33:00.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1440,"price":544.9599,"value":784742.256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $544.67 to $545.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27436,"source":{"system":"sec-edgar","filing":"0001636178-26-000023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000023/primarydocument.xml","form_type":"4"}},{"id":755699,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-06-02T20:33:00.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":117.76,"value":1177600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":28876,"source":{"system":"sec-edgar","filing":"0001636178-26-000023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000023/primarydocument.xml","form_type":"4"}},{"id":759222,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Stock Option","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":50000,"derivative":{"exercise_price":117.76,"exercise_date":"2023-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":759221,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":228,"price":571.4811,"value":130297.6908,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $571.06 to $571.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18876,"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":759220,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":332,"price":570.4955,"value":189404.506,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $570.01 to $570.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19104,"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":759219,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":844,"price":568.9008,"value":480152.2752,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $568.55 to $569.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19436,"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":759218,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":1605,"price":567.9143,"value":911502.4515,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $567.46 to $568.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20280,"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":759217,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":934,"price":566.8663,"value":529453.1242,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $566.46 to $567.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21885,"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":759216,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":893,"price":565.9956,"value":505434.0708,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $565.42 to $566.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22819,"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":759215,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":1208,"price":564.8205,"value":682303.164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $564.40 to $565.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23712,"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":759214,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":1675,"price":563.8743,"value":944489.4525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $563.39 to $564.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24920,"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":759213,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":1961,"price":562.7676,"value":1103587.2636,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $562.38 to $563.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26595,"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":759212,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":320,"price":561.4823,"value":179674.336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $561.09 to $562.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28556,"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":759211,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-29T20:37:44.000Z","date":"2026-05-28","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":117.76,"value":1177600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":28876,"source":{"system":"sec-edgar","filing":"0001636178-26-000022","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000022/primarydocument.xml","form_type":"4"}},{"id":762581,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Stock Option","published_at":"2026-05-27T20:31:36.000Z","date":"2026-05-26","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."}],"balance_after":60000,"derivative":{"exercise_price":117.76,"exercise_date":"2023-03-15","expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001636178-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000021/primarydocument.xml","form_type":"4"}},{"id":762580,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":36101,"kind":"person","name":"EDGEMOND JAMES","position":1,"cik":"0001636178","reported_name":"EDGEMOND JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO AND TREASURER"}}],"security":"Common Stock","published_at":"2026-05-27T20:31:36.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":760,"price":578.1213,"value":439372.188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"This transaction was executed in multiple trades at prices ranging from $577.84 to $578.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18876,"source":{"system":"sec-edgar","filing":"0001636178-26-000021","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000163617826000021/primarydocument.xml","form_type":"4"}}],"next_cursor":"2026-05-27T20:31:36.000000Z,762580"}